Whom do older adults trust most to provide information about prescription drugs?

American Journal Geriatric Pharmacotherapy

Volumn 7, Issue 2, 2009, Pages 105-116

  Donohue, Julie M ^a   Huskamp, Haiden A ^b   Wilson, Ira B ^c   Weissman, Joel ^d  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cost related nonadherence; patient provider communication; prescription drug costs; trust in physicians

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DOCTOR PATIENT RELATION; DRUG COST; DRUG EFFICACY; DRUG INFORMATION; ELDERLY CARE; FAMILY; FEMALE; FRIEND; HEALTH SURVEY; HUMAN; INTERNET; INTERPERSONAL COMMUNICATION; MALE; NURSE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; TRUST;

AGE FACTORS; AGED; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; DRUG COSTS; DRUG INFORMATION SERVICES; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PHYSICIAN-PATIENT RELATIONS; PRESCRIPTION DRUGS; TRUST; UNITED STATES;

EID: 65549088836     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2009.04.005     Document Type: Article

References (48)

1. Safran D.G., Neuman P., Schoen C., et al. Prescription drug coverage and seniors: How well are states closing the gap?. Health Aff (Millwood) (2002) W253-W268 Suppl Web Exclusives
2. Safran D.G., Newman P., Schoen C., et al. Prescription drug coverage and seniors: Findings from a 2003 national survey. Health Aff (Millwood) (2005) W5-W152 Suppl Web Exclusives
3. Safran D.G., Newman P., Schoen C., et al. Prescription drug coverage and seniors: Findings from a 2003 national survey. Health Aff (Millwood) (2005) W155-W166 Suppl Web Exclusives
4. Piette J.D., Heisler M., and Wagner T.H. Cost-related medication underuse: Do patients with chronic illnesses tell their doctors?. Arch Intern Med. 164 (2004) 1749-1755
5. Soumerai S.B., Pierre-Jacques M., Zhang F., et al. Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: A national survey 1 vear before the Medicare drug benefit. Arch Intern Med. 166 (2006) 1829-1835
6. Piette J.D., Heisler M., and Wagner T.H. Cost-related medication underuse among chronically ill adults: The treatments people forgo, how often, and who is at risk. Am J Public Health. 94 (2004) 1782-1787
7. Madden J.M., Graves A.J., Zhang F., et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 299 (2008) 1922-1928
8. Artz M.B., Hadsall R.S., and Schondelmeyer S.W. Impact of generosity level of outpatient prescription drug coverage on prescription drug events and expenditure among older persons. Am J Public Health. 92 (2002) 1257-1263
9. Maio V., Pizzi L., Roumm A.R., et al. Pharmacy utilization and the Medicare Modernization Act. Milbank Q. 83 (2005) 101-130
10. Hsu J., Price M., Huang J., et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 354 (2006) 2349-2459
11. Adams A.S., Soumerai S.B., and Ross-Degnan D. Use of antihypertensive drugs by Medicare enrollees: Does type of drug coverage matter?. Health Aff (Millwood) 20 (2001) 276-286
12. Tseng C., Brook R.H., Keeler E., and Mangione C.M. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients. JAMA. 290 (2003) 222-227
13. Fischer M.A., and Avorn I. Economic implications of evidence-based prescribing for hypertension: Can better care cost less?. JAMA. 291 (2004) 1850-1856
14. Fischer M.A., and Avorn I. Potential savings from increased Lise of generic drugs in the elderly: What the experience ot Medicaid and other insurance programs means for a Medicare drug benefit. Pharmacoepidemiol Drug Saf. 13 (2004) 207-214
15. Wilson I.B., Schoen C., Neuman P., et al. Phvsician-patient communication about prescription medication nonadherence: A 50-state study of America's seniors. J Gen Intern Med. 22 (2007) 6-12
16. Korn L.M., Reichert S., Simon T., and Halm E.A. Improving physicians' knowledge of the costs of common medications and willingness to consider costs when prescribing. J Gen Intern Med. 18 (2003) 31-37
17. Shih Y.C., and Sleath B.L. Health care provider knowledge of drug formulary status in ambulatory care settings. Am J Health Syst Pharm. 61 (2004) 2657-2663
18. Reichert S., Simon T., and Halm E.A. Physicians' attitudes about prescribing and knowledge of the costs of common medication. Arch Intern Med. 160 (2000) 2799-2803
19. Shrank W.H., Young H.N., Ettner S.E., et al. Do the incentives in 3 tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey [published correction appears in Am J Manag Care. 2005;11:180]. Am J Manag Care. 11 (2005) 16-22
20. Goold S.D. Trust and the ethics of health care institutions. Hastings Cent Rep. 31 (2001) 26-33
21. Eysenbach G., Powell J., Kuss O., and Sa E.R. Empirical studies assessing the quality of health information for consumers on the world wide web: A systematic review. JAMA. 287 (2002) 2691-2700
22. Thorn D.H., Ribisi K.M., Stewart A.L., Luke D.A., and for the Stanford Trust Study Physicians. Further validation and reliability testing of the Trust in Physician Scale. Med Care. 37 (1999) 510-517
23. Piette J.D., Heisler M., Krein S., and Kerr E.A. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 165 (2005) 1749-1755
24. Thom D.H., Hall M.A., and Pawlson L.G. Measuring patients' trust in physicians when assessing quality of care. Health Aff (Millwood) 23 (2004) 124-132
25. Pearson S.D., and Raeke L.H. Patients' trust in physicians: Many theories, few measures, and little data. J Gen Intern Med. 15 (2000) 509-513
26. Thom D.H., and for the Stanford Trust Study Physicians. Physician behaviors that predict patient trust. J Fam Pract. 50 (2001) 323-328
27. Hibbard J.H., Mahoney E.R., Stockard J., and Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res. 40 (2005) 1918-1930
28. Soumerai S.B., Pierre-Jacques M., Zhang F., et al. Cost-related medication nonadhcrence among elderly and disabled Medicare beneficiaries: A national survey 1 year before the Medicare drug benefit. Arch Intern Med. 166 (2006) 1829-1835
29. Pierre-Jacques M., Safran D.G., Zhang F., et al. Reliability of new measures of cost-related medication non-adherence. Med Care. 46 (2008) 444-448
30. Anderson L.A., and Dedrick R.F. Development of the Trust in Physician scale: A measure to assess interpersonal trust in patient-physician relationships. Psychol Rep. 67 (1990) 1091-1100
31. Donohue J.M., Cevasco M., and Rosenthal M.B. A decade of direct-to-consumer advertising of prescription drugs. N Eryl J Med. 357 (2007) 673-681
32. Crawford G.G., and Shum M. Uncertainty and learning in pharmaceutical demand. Econometrica 73 (2005) 1137-1173
33. Mechanic D. Trust and informed consent to rationing. Milbank Q. 72 (1994) 217-223
34. Mechanic D. Managed care as a target of distrust. JAMA. 277 (1997) 1810-1811
35. Safran D.G., Kosinski M., Tarlov A.R., et al. The Primary Care Assessment Survey: Tests of data quality and measurement performance. Med Care. 36 (1998) 728-739
36. Kao A.C., Green D.C., Davis N.A., et al. Patients' trust in their physicians: Effects of choice, continuity, and payment method. J Gen Intern Med. 13 (1998) 681-686
37. Kao A.C., Green D.C., Zaslavsky A.M., et al. The relationship between method of physician payment and patient trust. JAMA. 280 (1998) 1708-1714
38. Alexander G.C., Casalino L.P., and Meltzer D.O. Physician strategies to reduce patients' out-of-pocket prescription costs. Arch Intern Med. 165 (2005) 633-636
39. Hanlon I.T., Schmader K.E., Ruby C.M., and Weinberger M. Suboptimal prescribing in elderly inpatients and outpatients. J Am Geriatr Soc. 49 (2001) 200-209
40. Spinewine A., Schmader K.E., Barber N., et al. Appropriate prescribing in elderly people: How well can it be measured and optimised?. Lancet 370 (2007) 173-184
41. Wilson I.B., Schoen C., Neuman P., et al. Physician-patient communication about prescription medication nonadherence: A 50-state study of America's seniors. J Gen Intern Med. 22 (2006) 6-12
42. Alexander G.C., Casalino L.P., and Meitzer D.O. Patient-physician communication about out-of-pocket costs. JAMA. 290 (2003) 953-958
43. Tarn D.M., Paterniti D.A., Heritage J., et al. Physician communication about the cost and acquisition of newly prescribed medications. Am J Manag Care. 12 (2006) 657-664
44. Tseng C., Dudley R.A., Brook R.H., et al. Elderly patients' preferences and experiences with providers in managing their drug costs. J Am Geriatr Soc. 55 (2007) 1974-1980
45. Fischer M., Vogeli C., Stedman M., et al. Effect of electronic prescribing with formulary decision support on medication use and cost. Arch Intern Med. 168 (2008) 2433-2439
46. Gans D., Kralewski J., Hammons T., and Dowd B. Medical groups' adoption of electronic health records and information systems. Health Aff (Millwood). 24 (2005) 1323-1333
47. Kaiser Family Foundation and Health Research & Educational Trust. Employer health benefits: 2006 Annual survey. http://www.kff.org/insurance/7527/upload/7527.pdf Accessed April 2, 2009.
48. Kaiser Family Foundation. Medicare fact sheet. The Medicare Prescription Drug Benefit (November 2006). http://www.kff.org/medicare/upload/7044-05.pdf Accessed April 2, 2009.